Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 55 min ago
Peer-reviewedCC BYAlzheimer's & dementia : the journal of the Alzheimer's Association

Tyrosine kinase inhibitor use and risk of neurodegenerative disease: A Swedish population‐based cohort study

  1. 1Karolinska Institutet
  2. 2German Center for Neurodegenerative Diseases (DZNE)

Related

  1. Precarious employment and its impact on chronic obstructive pulmonary disease in the Swedish working population – a longitudinal register-based study
    Filippa Lundh, Virginia Gunn, Bertina Kreshpaj +7
    Scandinavian Journal of Work, Environment & HealthPeer-reviewedCC BY 4.0Full textEpidemiology & public healthPMC
  2. A Novel ACLY Inhibitor Induces Transcriptional and Metabolic Reprogramming to Overcome Tyrosine kinase inhibitor Resistance in Lymphoma
    N. Pattabiraman, C. Lobello, D. Rushmore +9
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  3. Aplastic Anaemia in a Chronic Lymphocytic Leukaemia Patient Treated With Acalabrutinib, a Bruton Tyrosine Kinase Inhibitor—Case Report
    Zachray Wei, Tamara Marconi, Lucy Tuck +1
    EJHaemPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
  4. Effectiveness of Adding GLP‐1 Receptor Agonists to SGLT2 Inhibitor Therapy in Chronic Kidney Disease: A Population Based Study
    Hussain Salim, Shaheer Qureshi, Gaurav S. Gulsin +7
    Diabetes, Obesity & MetabolismPeer-reviewedCC BY 4.0Full textEndocrinology & metabolismPMC
  5. A noncanonical function of the tyrosine degradation enzyme FAH drives CDK4/6 inhibitor resistance in breast cancer
    Jenny Högström, Hanna M. Doh, Aidan Kump +17
    Science AdvancesPeer-reviewedCC BYGeneral medicineCrossref
BibTeX
@article{wittstrom2026tyrosine,
  title = {{Tyrosine kinase inhibitor use and risk of neurodegenerative disease: A Swedish population‐based cohort study}},
  author = {Felix Wittström and Enoch Yi‐Tung Chen and Iris Blotenberg and Torsten Dahlén},
  journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
  year = {2026},
  month = oct,
  url = {https://europepmc.org/article/PMC/PMC13655210},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Tyrosine kinase inhibitor use and risk of neurodegenerative disease: A Swedish population‐based cohort study
AU  - Felix Wittström
AU  - Enoch Yi‐Tung Chen
AU  - Iris Blotenberg
AU  - Torsten Dahlén
PY  - 2026
DA  - 2026/10/01
JO  - Alzheimer's & dementia : the journal of the Alzheimer's Association
UR  - https://europepmc.org/article/PMC/PMC13655210
SN  - 1552-5260
SN  - 1552-5279
ER  -